Trial Profile
A prospective study of cangrelor P2Y12-inhibition in patients with ST-segment elevation myocardial infarction : A real world experience
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2016
Price :
$35
*
At a glance
- Drugs Cangrelor (Primary) ; Ticagrelor
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 06 Oct 2016 New trial record